Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.36 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.36 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | PPARA | Q07869 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10260776 | 0.97 | CA12 (0.40) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL10260212 | 0.96 | PIM1 (0.40) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL10259819 | 0.96 | PIM1 (0.40) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL10260202 | 0.96 | PIM1 (0.40) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL15334682 | 0.95 | PIM1 (0.39) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL10259359 | 0.94 | CA12 (0.42) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL10259765 | 0.93 | ENPP3 (0.41) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL10259759 | 0.90 | PIM1 (0.36) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL15334684 | 0.90 | GPR84 (0.37) | CA12CA1CA2CA9PIM1 | |
| SCHEMBL15334680 | 0.90 | ABCG2 (0.39) | CA12CA1CA2CA9PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563972-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-22 | — | — | US | disclosed |
| US-8563972-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-22 | — | — | US | disclosed |
| US-20130248838-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248838-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-8471251-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-8471251-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-20 | — | — | US | disclosed |
| US-8324619-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| US-8324619-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-04 | — | — | US | disclosed |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-09-13 | — | — | US | disclosed |
| US-8212239-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-8212239-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-02-24 | — | — | US | disclosed |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319571-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
| US-20120228593-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | CA12 1607/4885CA1 1086/4885CA2 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.